Home Cart 0 Sign in  
X

[ CAS No. 1214741-19-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1214741-19-1
Chemical Structure| 1214741-19-1
Chemical Structure| 1214741-19-1
Structure of 1214741-19-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1214741-19-1 ]

Related Doc. of [ 1214741-19-1 ]

Alternatived Products of [ 1214741-19-1 ]

Product Details of [ 1214741-19-1 ]

CAS No. :1214741-19-1 MDL No. :MFCD20488025
Formula : C11H15NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :PBHXYYXEZQXDLB-LDYMZIIASA-N
M.W : 225.24 Pubchem ID :77174616
Synonyms :

Calculated chemistry of [ 1214741-19-1 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.73
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 59.04
TPSA : 63.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 0.93
Log Po/w (WLOGP) : 0.09
Log Po/w (MLOGP) : 0.53
Log Po/w (SILICOS-IT) : 1.09
Consensus Log Po/w : 0.82

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.69
Solubility : 4.59 mg/ml ; 0.0204 mol/l
Class : Very soluble
Log S (Ali) : -1.85
Solubility : 3.16 mg/ml ; 0.014 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.32
Solubility : 10.8 mg/ml ; 0.048 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.33

Safety of [ 1214741-19-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1214741-19-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1214741-19-1 ]
  • Downstream synthetic route of [ 1214741-19-1 ]

[ 1214741-19-1 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 107-31-3 ]
  • [ 171284-84-7 ]
  • [ 1214741-19-1 ]
YieldReaction ConditionsOperation in experiment
61%
Stage #1: With 1,3-dimethyl-2-imidazolidinone; chloro-trimethyl-silane; copper(l) chloride; lithium hexamethyldisilazane In tetrahydrofuran at -60 - 10℃; for 0.5 h; Inert atmosphere
Stage #2: With trifluoroacetic acid In water at 5 - 25℃; for 3.66667 h;
To a 2 L three neck flask equipped with an agitator, thermometer, reflux condenser, and a nitrogen inlet were charged XIV (100 g, 0.5 mol), CuCl (10 g), DMI (100 mL), THF (1.2 L), and methyl formate (100 mL). After cooling to below [−60]° C., LHMDS (700 mL, 1.0 M in THF) was charged at a rate such that the temperature did not exceed −60° C. After addition of LHMDS, TMSCl was charged at a rate such that the temperature did not exceed [−60]° C. The mixture was warmed to between 0 and 10° C. over 30 min and the batch was concentrated in vacuum to 250 mL and EtOAc (300 mL) was added. To a mixture of citric acid (120 g), water (1 L), and EtOAc (1 L) at 5° C. was then transferred the crude reaction mixture over 30 min while maintaining a temperature between 0 and 15° C. The flask containing the crude mixture was then rinsed with EtOAc (200 mL). After agitating for 10 min, the layers were separated and the organic layer was sequentially washed with 12.5percent aq. citric acid (800 mL), 10percent aq. citric acid (700 mL) and 8percent aq. citric acid solution (600 mL). To a mixture of the organic layer and water (300 mL) at 5° C., was charged trifluoroacetic acid (30 mL) over 10 min while maintaining a temperature between 5 and 15° C. After completing the addition, the mixture was warmed to 25° C. and agitated for 3.5 h. An aqueous solution of KHCO3 (200 mL, 20percent) was charged over 30 min while maintaining a temperature below 20° C., followed by saturated NaCl solution (500 mL) and the layers were separated and split. The aqueous layer was back extracted with EtOAc (250 mL). The EtOAc fraction was washed with saturated NaCl solution (500 mL). Water (35 mL) was charged to the combined organic layers and the solution was concentrated in vacuum to a final volume of 100 mL. MTBE (400 mL) was charged and the mixture was concentrated in vacuum to a final volume of 100 mL. Additional MTBE (400 mL) was charged and the suspension was agitated for 2 h at RT. The resulting slurry was filtered, rinsed with MTBE (200 mL) and XV was obtained in 61percent yield (70 g) after drying in vacuum at 45° C. for 12 h. MP 196° C.-198° C. 1H NMR (400 MHz in CDCl3): δ 9.7 (s, 1H), 5.5 (s, 1H), 2.7 (m, 1H), 2.6 (m, 1H), 2.4 (m, 2H), 0.9 (s, 9H). 13CNMR (400 MHz, CDCl3): 192.0, 181.1, 169.7, 97.6, 73.4, 36.5, 31.7, 30.6, 24.6. ES-MS: [M+H+]calcd for C11H15NO4: 226.10. found: 226.27.
Reference: [1] Patent: US2014/31549, 2014, A1, . Location in patent: Paragraph 0146; 0147
[2] Organic Letters, 2018, vol. 20, # 6, p. 1509 - 1512
  • 2
  • [ 98-79-3 ]
  • [ 1214741-19-1 ]
Reference: [1] Patent: US2014/31549, 2014, A1,
[2] Organic Letters, 2018, vol. 20, # 6, p. 1509 - 1512
  • 3
  • [ 630-19-3 ]
  • [ 1214741-19-1 ]
Reference: [1] Patent: US2014/31549, 2014, A1,
[2] Organic Letters, 2018, vol. 20, # 6, p. 1509 - 1512
  • 4
  • [ 1214741-19-1 ]
  • [ 27200-84-6 ]
  • [ 1214741-20-4 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With sodium hexamethyldisilazane In toluene at 10℃; for 1 h;
Stage #2: at 10℃;
To a 3-neck 1-L flask equipped with a thermometer and mechanical stirrer were charged Ph3PCH3Br (122.9 g; 344.1 mmol) and toluene (100 mL). At 10° C., a solution of NaHMDS in toluene (540 mL, 13percent) was added slowly to maintain the temperature at 10° C. This slurry was agitated at 10° C. for 1 h and then added slowly to a slurry of XV (50 g, 222 mmol) in toluene (100 mL) at 10° C., over a period of 2-4 h via peristaltic pump. After stirring for an additional hour, the batch was quenched into a solution of NaCl (10percent aqueous), AcOH (38.5 mL, 666 mmol), and toluene (50 mL) over 30 min at 25° C. The resulting mixture was stirred for 30 min and the layers were settled, split and the lower aqueous layer was removed. The organic layer was then treated with MgCl2 powder (70 g, 776 mmol) for 2 h at RT. The solids were then filtered off and the solid MgCl2-triphenylphosphin oxide complex was washed with MTBE (100 mL). The organic filtrates were combined, washed with aq. NaCl (100 mL, 10percent) and concentrated to 100 mL in vacuum. To the resulting slurry was charged heptane (400 mL) and the volume was reduced to 100 mL in vacuum. Additional heptane (400 mL) was added and the volume was reduced to 250 mL in vacuum. A third portion of heptane (400 mL) was added; the batch was then cooled to 0° C. over 2 h and stirred for another 2 h at this temperature. The solids were then removed by filtration and washed with ice-cold N-heptane (200 mL). The wet cake was dried under vacuum at 30° C. for 18 h to produce 62 g of XVI (63percent yield) as an off-white solid. Mp 85° C.-87° C. 1H-NMR (CDCl3) δ 5.98 (m, 1H), 5.31 (m, 3H), 2.56 (m, 1H), 2.17 (m, 3H), 0.81 (s, 9H). ES-MS: [M+H+]calcd for C12H18NO3: 224.12. found: 224.38.
Reference: [1] Patent: US2014/31549, 2014, A1, . Location in patent: Paragraph 0148; 0149
  • 5
  • [ 1214741-19-1 ]
  • [ 1214741-21-5 ]
Reference: [1] Patent: US2014/31549, 2014, A1,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 1214741-19-1 ]

Rolapitant Related Intermediates

Chemical Structure| 1214741-14-6

[ 1214741-14-6 ]

(S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate

Chemical Structure| 196929-78-9

[ 196929-78-9 ]

(R)-2-Methyl-2-propanesulfinamide

Chemical Structure| 1214741-20-4

[ 1214741-20-4 ]

(3R,7AR)-3-(tert-butyl)-7a-vinyldihydropyrrolo[1,2-c]oxazole-1,5(3H,6H)-dione

Chemical Structure| 582-24-1

[ 582-24-1 ]

2-Hydroxy-1-phenylethanone

Chemical Structure| 98-79-3

[ 98-79-3 ]

(S)-5-Oxopyrrolidine-2-carboxylic acid

Related Functional Groups of
[ 1214741-19-1 ]

Aldehydes

Chemical Structure| 95715-87-0

[ 95715-87-0 ]

(R)-tert-Butyl 4-formyl-2,2-dimethyloxazolidine-3-carboxylate

Similarity: 0.63

Chemical Structure| 102308-32-7

[ 102308-32-7 ]

(S)-3-Boc-2,2-dimethyloxazolidine-4-carboxaldehyde

Similarity: 0.63

Chemical Structure| 117625-90-8

[ 117625-90-8 ]

1-Boc-2-Formylpyrrolidine

Similarity: 0.59

Chemical Structure| 157634-02-1

[ 157634-02-1 ]

tert-Butyl 2-formylpiperidine-1-carboxylate

Similarity: 0.58

Chemical Structure| 59379-02-1

[ 59379-02-1 ]

tert-Butyl 3-formylpyrrolidine-1-carboxylate

Similarity: 0.55

Ketones

Chemical Structure| 180854-44-8

[ 180854-44-8 ]

(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate

Similarity: 0.69

Chemical Structure| 1799811-83-8

[ 1799811-83-8 ]

(R)-1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate

Similarity: 0.67

Chemical Structure| 756486-14-3

[ 756486-14-3 ]

(S)-1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate

Similarity: 0.67

Chemical Structure| 81357-18-8

[ 81357-18-8 ]

1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate

Similarity: 0.67

Chemical Structure| 433683-01-3

[ 433683-01-3 ]

tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

Similarity: 0.66

Related Parent Nucleus of
[ 1214741-19-1 ]

Other Aliphatic Heterocycles

Chemical Structure| 1214741-20-4

[ 1214741-20-4 ]

(3R,7AR)-3-(tert-butyl)-7a-vinyldihydropyrrolo[1,2-c]oxazole-1,5(3H,6H)-dione

Similarity: 0.90

Chemical Structure| 1214741-21-5

[ 1214741-21-5 ]

(3R,7aR)-3-(tert-butyl)-1-hydroxy-7a-vinyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one

Similarity: 0.75

Chemical Structure| 99208-71-6

[ 99208-71-6 ]

(S)-3,3-Dimethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one

Similarity: 0.71

Chemical Structure| 197142-34-0

[ 197142-34-0 ]

(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid

Similarity: 0.69

Chemical Structure| 291775-59-2

[ 291775-59-2 ]

(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid

Similarity: 0.69